Research ArticleOpen AccessGoogle Scholar indexed
Test of the Popular Benzodiazepine Alprazolam in a Positive Conditioned Place-Preference Model in Female Rats
Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
NEMA Inc., Naples, FL, USA
Pharmaceutical Sciences (Form. Faculty), Hokkaido University of Science, Hokkaido, Japan
Enalare Therapeutics, Naples, FL, USA
Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
Neumentum Inc., Morristown, NJ, USA
School of Pharmacy (Prof Em.), Temple University, Philadelphia, PA, USA
College of Pharmacy (Adjunct), University of Arizona, Tucson, AZ, USA
- 1 Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
- 2 Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
- 3 Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
- 4 Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
- 5 NEMA Inc., Naples, FL, USA
- 6 Pharmaceutical Sciences (Form. Faculty), Hokkaido University of Science, Hokkaido, Japan
- 7 Enalare Therapeutics, Naples, FL, USA
- 8 Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
- 9 Department of Pharmacology, and Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA
- 10 Neumentum Inc., Morristown, NJ, USA
- 11 School of Pharmacy (Prof Em.), Temple University, Philadelphia, PA, USA
- 12 College of Pharmacy (Adjunct), University of Arizona, Tucson, AZ, USA
Pharmacology & Pharmacy·Volume 12 (2021)·Pages 100–108·Published 31 May 2021·DOI10.4236/pp.2021.125010
Copy link · social · email
Abstract
The benzodiazepines were introduced into medical practice during the 1960s. At the time, they represented a safer alternative to extant therapies used for anxiety, such as the barbiturates. However, on September 23, 2020, the United States FDA indicated that more is needed to be known about the initiation, continuation, and discontinuation of the us e of these widely-used drugs with publication of the announcement “ to address the serious risks of abuse, addiction, physical dependence, and withdrawal reactions, the U.S. Food and Drug Administration (FDA) is requiring the Boxed Warning be updated for all benzodiazepine medicines. ” Because for many years , there has been a sparsity of research on these drugs, relevant information is unfortunately lacking at this critical time. It is therefore valuable to (re)establish animal models and begin to collect relevant data. We here use a model of conditioned place preference (CPP) which suggests that the representative benzodiazepine alprazolam induces positive place preference in female rats.
KeywordsBenzodiazepineConditioned PlacepreferenceAlprazolamFemale Rats
- López-Munoz, F., álamo, C. and García-García, P. (2011) The Discovery of Chlordiazepoxide and the Clinical Introduction of Benzodiazepines: Half a Century of Anxiolytic Drugs. Journal of Anxiety Disorders, 25, 554-562. https://doi.org/10.1016/j.janxdis.2011.01.002
- Wick, J.Y. (2013) The History of Benzodiazepines. The Consultant Pharmacist, 28, 538-548. https://doi.org/10.4140/TCP.n.2013.538
- Griffin III, C.E., Kaye, A.M., Bueno, F.R. and Kaye, A.D. (2013) Benzodiazepine Pharmacology and Central Nervous System-Mediated Effects. Ochsner Journal, 13, 214-223.
- Schmitz, A. (2016) Benzodiazepine Use, Misuse, and Abuse: A Review. Mental Health Clinician, 6, 120-126. https://doi.org/10.9740/mhc.2016.05.120
- Agarwal, S.D. and Landon, B.E. (2019) Patterns in Outpatient Benzodiazepine Prescribing in the United States. JAMA Network Open, 2, e187399. https://doi.org/10.1001/jamanetworkopen.2018.7399
- Guina, J. and Merrill, B. (2018) Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. Journal of Clinical Medicine, 7, Article ID: 17. https://doi.org/10.3390/jcm7020017
- Ashman, J.J., Schappert, S.M. and Santo, L. (2020) Emergency Department Visits among Adults Aged 60 and Over: United States, 2014-2017. National Center for Health Statistics Data Brief, 367, 1-8.
- Santo, L., Rui, P. and Ashman, J.J. (2020) Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings from 2014-2016 National Ambulatory Medical Care Survey. National Health Statistics Reports, 137, 1-16.
- Rui, P., Santo, L. and Ashman, J.J. (2020) Trends in Opioids Prescribed at Discharge from Emergency Departments among Adults: United States, 2006-2017. National Health Statistics Reports, 135, 1-12.
- Longo, L.P. and Johnson, B. (2000) Addiction: Part I. Benzodiazepines—Side Effects, Abuse Risk and Alternatives. American Family Physician, 61, 2121-2128.
- Ashton, H. (1991) Protracted Withdrawal Syndromes from Benzodiazepines. Journal of Substance Abuse Treatment, 8, 19-28. https://doi.org/10.1016/0740-5472(91)90023-4
- Volkow, N.D., et al. (2010) Addiction: Decreased Reward Sensitivity and Increased Expectation Sensitivity Conspire to Overwhelm the Brain's Control Circuit. Bioessays, 32, 748-755. https://doi.org/10.1002/bies.201000042
- White, N.M. (2011) Reward: What Is It? How Can It Be Controlled from Behavior? In: Gottfried, J., Ed., Neurobiology of Sensation and Reward, CRC Press/Taylor & Francis, Boca Raton, 45-60.